HemoShear Revenue and Competitors
Estimated Revenue & Valuation
- HemoShear's estimated annual revenue is currently $11.2M per year.
- HemoShear's total funding is $60.1M.
Employee Data
HemoShear's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Head Platform and Early Discovery Sciences | Reveal Email/Phone |
2 | VP, Communications | Reveal Email/Phone |
3 | VP, Organization Development & HR | Reveal Email/Phone |
4 | Senior Director, Drug Discovery | Reveal Email/Phone |
5 | Director, Computational Biology | Reveal Email/Phone |
6 | Director Molecular Pharmacology | Reveal Email/Phone |
7 | Executive Director, Asset Development Team Leader, Early Clinical Development | Reveal Email/Phone |
8 | Chief Business Officer | Reveal Email/Phone |
9 | Chief Medical Officer | Reveal Email/Phone |
10 | Manager, IT Service Operations | Reveal Email/Phone |
HemoShear Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $3M | 39 | 3% | $28.3M | N/A |
#2 | $1.4M | 9 | -18% | N/A | N/A |
#3 | $5.3M | 34 | 3% | N/A | N/A |
#4 | $31.9M | 206 | 0% | N/A | N/A |
#5 | $0.6M | 4 | -43% | N/A | N/A |
#6 | $4.3M | 55 | -52% | $56.5M | N/A |
#7 | $0.3M | 2 | 0% | N/A | N/A |
#8 | $5.4M | 35 | 21% | N/A | N/A |
#9 | $1.9M | 12 | 0% | N/A | N/A |
#10 | $2.6M | 34 | -11% | $9.8M | N/A |
What Is HemoShear?
HemoShear LLC is a biotechnology research company that combines its scientific expertise with its proprietary platform technology in research collaborations with pharmaceutical companies to accelerate drug discovery and development. HemoShear has expertise in the areas of human and animal biology, bioinformatics and molecular profiling for target identification and validation, cell-signaling pathway analysis, sophisticated methods to quantify target genes and proteins, assessment of molecular pharmacology, and methods to determine mechanisms of action for drug efficacy and safety. HemoShear's technology platform can be adapted to replicate the biology of human or animal organ systems in both healthy and disease-prone states by applying physiologically accurate hemodynamic forces to primary cell cultures. HemoShear is currently collaborating with several large pharmaceutical companies on programs that span the drug discovery and development spectrum. HemoShear is a privately held company located in Charlottesville, Virginia. To learn more about HemoShear, visit www.hemoshear.com.
keywords:Biotechnology
$60.1M
Total Funding
N/A
Number of Employees
$11.2M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
HemoShear News
CHARLOTTESVILLE, Va., July 22, 2021 /PRNewswire/ -- HemoShear Therapeutics, Inc., a clinical stage company developing treatments for rare metabolic disorders, today announced that the first two patients have been dosed in the HERO (HElp Reduce Organic Acids) Phase 2 clinical trial of HST5040, ...
HemoShear Therapeutics, Inc., a Charlottesville, Va.-based clinical stage company developing treatments for rare metabolic disorders, has raised $40m in Series A financing. The round was led by Suvretta Capital with participation from Janus Henderson Investors, Adage Capital Management LP and o ...
HemoShear Therapeutics, Inc., a Charlottesville, Va.-based clinical stage company developing treatments for rare metabolic disorders, has raised $40m in Series A financing. The round was led by Suvretta Capital with participation from Janus Henderson Investors, Adage Capital Management LP and o ...